Kenvue rises as CEO steps down amid board's strategic review
ReutersJul 14, 2025 11:21 AM
Shares of consumer healthcare co Kenvue KVUE.N rise 3% to $22 in premarket trading
Co appoints Kirk Perry as interim CEO effective immediately after departure of CEO Thibaut Mongon
Perry was with Procter & Gamble PG.N for 23 years where he held several general management and marketing roles
The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to simplify the company’s portfolio and how it operates - KVUE
Co announces prelim Q2 adj. profit of 28 to 29 cents per share, in-line with estimates, as per data compiled by LSEG
Up to last close, KVUE down 0.05% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Beyond Gold, What Is the Next Safe-Haven Asset Choice?
TradingKey - Against the backdrop of heightened global market volatility, escalating geopolitical risks, and mixed macroeconomic signals, market safe-haven sentiment continues to intensify. In the face of rising uncertainty, an increasing number of investors are seeking safe havens capable of wealth preservation and risk mitigation.TradingKey
7 hours ago
Will Micron Be the 2026 AI Winner as the Memory Supercycle Begins?
Recently, Micron has focused on premium areas such as High-Bandwidth Memory that plays alongside accelerators to feed AI models, and adding capacity with an eye on pricing discipline.TradingKey
11 hours ago
NFT Price Collapse 2026: Full Market Analysis and Digital Asset Recovery Forecast
Analyze the 2026 NFT price collapse and the pivot to digital utility. From Bored Ape floor stability to Solana NFT news and NFT credit cards, explore the recovery forecast.TradingKey
23 hours ago
